Skip to main content
Log in

Target site antimicrobial activity of colistin might be misestimated if tested in conventional growth media

  • Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

Cation-dependent inhibition of antimicrobial activity was reported for polymyxin antibiotics. Ca2+ and Mg2+ concentrations recommended by the Clinical and Laboratory Standards Institute (CLSI) for the supplementation of Müller–Hinton broth (MHB) are markedly lower than interstitial space fluid (ISF) concentrations in vivo. Hence, it was speculated that the antimicrobial activity of colistin might be overestimated if tested using conventional cation-adjusted MHB. The antimicrobial activity of colistin against n = 100 clinical isolates of Pseudomonas aeruginosa, Acinetobacter baumannii, Klebsiella pneumoniae and Escherichia coli (n = 25 each) was evaluated by broth microdilution and, for selected isolates, by time–kill curves, in MHB without cations (MHBONLY), MHB supplemented with 25 mg/L Ca2+ and 12.5 mg/L Mg2+ according to CLSI recommendations (MHBCLSI), and in MHB adjusted to 50 mg/L Ca2+ and 20 mg/L Mg2+ simulating ISF concentrations (MHBISF). The minimum inhibitory concentration (MIC) values of colistin against the vast majority of isolates of both P. aeruginosa and A. baumannii increased significantly with higher cation concentrations. The susceptibility of K. pneumoniae isolates to colistin did not show significant changes between cation-supplemented media, while the MICs of E. coli decreased with ascending cation concentrations. These findings were confirmed in time–kill studies, where colistin killing against P. aeruginosa 1514 and A. baumannii 1485 declined with increasing cation concentrations. Contrarily, the killing of selected concentrations of colistin against K. pneumoniae 15 and E. coli 16 was enhanced in the presence of increasing cation concentrations. The present data suggest that the clinical antimicrobial activity of colistin might be misestimated in vitro if tested in conventional growth media.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Li J, Nation RL, Milne RW, Turnidge JD, Coulthard K (2005) Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Int J Antimicrob Agents 25(1):11–25. doi:10.1016/j.ijantimicag.2004.10.001

    Article  PubMed  Google Scholar 

  2. Chen CC, Feingold DS (1972) Locus of divalent cation inhibition of the bactericidal action of polymyxin B. Antimicrob Agents Chemother 2(5):331–335

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Davis SD, Iannetta A, Wedgwood RJ (1971) Activity of colistin against pseudomonas aeruginosa: inhibition by calcium. J Infect Dis 124(6):610–612

    Article  CAS  PubMed  Google Scholar 

  4. Newton BA (1953) Reversal of the antibacterial activity of polymyxin by divalent cations. Nature 172(4369):160–161

    Article  CAS  PubMed  Google Scholar 

  5. Clinical and Laboratory Standards Institute (CLSI) (2014) Performance standards for antimicrobial susceptibility testing; Twenty-fourth informational supplement. CLSI document M100-S24. CLSI, Wayne, PA

  6. Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna (2014) Parameter catalogue, reference values. Home page at: http://www.kimcl.at

  7. Karvanen M, Malmberg C, Mohamad A, Lagerbäck P, Friberg LE, Cars O (2011) Colistin is extensively lost during normal experimental conditions. Paper presented at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, IL, September 2011

  8. Albur M, Noel A, Bowker K, Macgowan A (2014) Colistin susceptibility testing: time for a review. J Antimicrob Chemother 69(5):1432–1434. doi:10.1093/jac/dkt503

    Article  CAS  PubMed  Google Scholar 

  9. Sader HS, Rhomberg PR, Flamm RK, Jones RN (2012) Use of a surfactant (polysorbate 80) to improve MIC susceptibility testing results for polymyxin B and colistin. Diagn Microbiol Infect Dis 74(4):412–414. doi:10.1016/j.diagmicrobio.2012.08.025

    Article  CAS  PubMed  Google Scholar 

  10. Hindler JA, Humphries RM (2013) Colistin MIC variability by method for contemporary clinical isolates of multidrug-resistant Gram-negative bacilli. J Clin Microbiol 51(6):1678–1684. doi:10.1128/JCM.03385-12

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Conflict of interest

Peter Matzneller declares that he has no conflict of interest.

Sabine Strommer declares that she has no conflict of interest.

Zoe Österreicher declares that she has no conflict of interest.

Dieter Mitteregger declares that he has no conflict of interest.

Markus Zeitlinger declares that he has no conflict of interest.

Compliance with ethical requirements

This article does not contain any studies with human or animal subjects.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Zeitlinger.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Matzneller, P., Strommer, S., Österreicher, Z. et al. Target site antimicrobial activity of colistin might be misestimated if tested in conventional growth media. Eur J Clin Microbiol Infect Dis 34, 1989–1994 (2015). https://doi.org/10.1007/s10096-015-2441-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-015-2441-7

Keywords

Navigation